Csenge Advisory Group’s Regenxbio RGNX Stock Holding History

Csenge Advisory Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9	Closed	–	–	1190
2018 Q3	$0	Buy	+9	New	+$648	﹤0.01%	1500

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Csenge Advisory Group's RGNX Position: Q4 2018 in Review

Csenge Advisory Group sold out of Regenxbio (RGNX) in Q4 2018, closing a stake of 9 shares.

Csenge Advisory Group first reported a position in RGNX in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 183 funds tracked by Wall St. Rank hold RGNX as of Q4 2018.

Csenge Advisory Group reported no remaining Regenxbio position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 9 Regenxbio shares in Q4 2018.
Csenge Advisory Group first reported a position in Regenxbio in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Regenxbio position peaked at $0 in Q3 2018.
183 funds tracked by Wall St. Rank held Regenxbio as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.